12/20/2024
7:00 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/17/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/06/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:00 PM | Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:06 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/07/2024
4:22 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
3:15 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
8:58 AM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4/A | |
10/08/2024
3:10 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
9:00 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
8:06 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:17 PM | MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:17 PM | Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:18 PM | Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
2:09 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
3:13 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B3 | |
07/21/2024
11:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form EFFECT | |
07/15/2024
3:43 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/20/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:14 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/07/2024
4:21 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 424B5 | |
06/07/2024
4:23 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:30 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
10:12 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/22/2024
10:08 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form ARS | |
03/21/2024
4:25 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEF 14A | |
03/21/2024
4:27 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/11/2024
3:30 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form PRE 14A | |
03/11/2024
3:15 PM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
7:30 AM | Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
